Expression profiling identifies responder and non-responder phenotypes to interferon- in multiple sclerosis

By McFarland H.F.  

Brain, Vol. 126, Iss. 6, 2003-06 ,pp. : 1419-1429

Oxford University Press

Access to resources Recommend Favorite

Gene-expression profiling in Parkinson’s disease: discovery of valid biomarkers, molecular targets and biochemical pathways

By Papapetropoulos Spiridon   McCorquodale Donald  

Future Neurology, Vol. 2, Iss. 1, 2007-01 ,pp. : 29-38

Future Medicine

Access to resources Recommend Favorite

Impact of Vitamin A Supplementation on RAR Gene Expression in Multiple Sclerosis Patients

By Bitarafan Sama   Harirchian Mohammad   Sahraian Mohammad   Keramatipour Mohammad   Beladi Moghadam Nahid   Togha Mansoureh   Nafissi Shahriar   Siassi Fereydoun   Eshraghian Mohammad   Mohammadzadeh Honarvar Niyaz   Ansar Hasti   Talebi Saeed   Saboor-Yarghi Ali  

Journal of Molecular Neuroscience, Vol. 51, Iss. 2, 2013-10 ,pp. : 478-484

Humana Press, Inc

Access to resources Recommend Favorite

CCR7 expression on peripheral blood lymphocytes is up-regulated following treatment of multiple sclerosis with interferon-beta

By Vallittu Anna-Maija   Saraste Maija   Airas Laura  

Neurological Research, Vol. 29, Iss. 8, 2007-12 ,pp. : 763-766

Maney Publishing

Access to resources Recommend Favorite

Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis

By Tajouri L.   Mellick A.S.   Ashton K.J.   Tannenberg A.E.G.   Nagra R.M.   Tourtellotte W.W.   Griffiths L.R.  

Molecular Brain Research, Vol. 119, Iss. 2, 2003-11 ,pp. : 170-183

Elsevier

Access to resources Recommend Favorite